Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1229737
Max Phase: Preclinical
Molecular Formula: C20H26N2O18P2S
Molecular Weight: 676.44
Molecule Type: Small molecule
Associated Items:
ID: ALA1229737
Max Phase: Preclinical
Molecular Formula: C20H26N2O18P2S
Molecular Weight: 676.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=Cc1ccc(-c2cn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H]3O)c(=O)[nH]c2=O)s1
Standard InChI: InChI=1S/C20H26N2O18P2S/c23-4-7-1-2-11(43-7)8-3-22(20(31)21-17(8)30)18-15(28)13(26)10(37-18)6-36-41(32,33)40-42(34,35)39-19-16(29)14(27)12(25)9(5-24)38-19/h1-4,9-10,12-16,18-19,24-29H,5-6H2,(H,32,33)(H,34,35)(H,21,30,31)/t9-,10-,12+,13-,14+,15-,16-,18-,19-/m1/s1
Standard InChI Key: KKHANSZRQMPJKN-PCGMDOMSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 676.44 | Molecular Weight (Monoisotopic): 676.0377 | AlogP: -3.25 | #Rotatable Bonds: 11 |
Polar Surface Area: 314.06 | Molecular Species: ACID | HBA: 18 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.73 | CX Basic pKa: | CX LogP: -3.57 | CX LogD: -8.32 |
Aromatic Rings: 2 | Heavy Atoms: 43 | QED Weighted: 0.08 | Np Likeness Score: 0.93 |
1. Descroix K, Pesnot T, Yoshimura Y, Gehrke SS, Wakarchuk W, Palcic MM, Wagner GK.. (2012) Inhibition of galactosyltransferases by a novel class of donor analogues., 55 (5): [PMID:22356319] [10.1021/jm201154p] |
2. Tedaldi L, Evitt A, Goos N, Jiang J, Wagner GK. (2014) A practical glycosyltransferase assay for the identification of new inhibitor chemotypes, 5 (8): [10.1039/C4MD00077C] |
3. Tedaldi L, Wagner GK. (2014) Beyond substrate analogues: new inhibitor chemotypes for glycosyltransferases, 5 (8): [10.1039/C4MD00086B] |
Source(1):